In Brief This Week: Qiagen; Atossa Genetics; Genomic Vision; In Silico Medicine; NextGxDx; AITbiotech; InterSystems; Intrexon | GenomeWeb

NEW YORK (GenomeWeb News) – Qiagen disclosed in its 2013 annual report filed with the US Securities and Exchange Commission that it acquired CLC Bio for $68.2 million, net of cash acquired. It added in the document that the deal was "not significant" to its overall consolidated financial statements. Qiagen announced the acquisition in October but had not disclosed the financial terms at that time.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.